dc.contributor.author | Makadzange, AT | |
dc.contributor.author | Gillespie, G | |
dc.contributor.author | Kimani, J | |
dc.contributor.author | Kiama, P | |
dc.contributor.author | Easterbrookayo, JJ | |
dc.contributor.author | Rowland-Jones, SL. | |
dc.contributor.author | Bwayo, JJ | |
dc.date.accessioned | 2013-06-29T07:21:39Z | |
dc.date.available | 2013-06-29T07:21:39Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Makadzange AT, Gillespie G, Kimani J, Kiama P, Easterbrook P, Bwayo JJ, Rowland-Jones S;Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 revL. | en |
dc.identifier.issn | http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/16439884 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/42092 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/16439884 | |
dc.description.abstract | HLA-B5701 and its related allele B5703 have been shown to be strongly associated with slow HIV-1 disease progression. To elucidate the effect of these alleles fully on disease progression it is essential to identify key HIV-1 epitopes that are restricted by these alleles. Here we describe the identification of a novel HLA-B5701, B5703 restricted epitope within HIV-1 rev, which accounted for up to 25 and 40% of the total cytotoxic T-lymphocyte responses in two patients | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi, | en |
dc.title | Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev | en |
dc.type | Article | en |
local.publisher | College of Health Sciences, | en |